PEA (Palmitoylethanolamide, PEAptimize™) supplier specification
Nutrition BioTech is a bulk palmitoylethanolamide (PEA) ingredient supplier and manufacturer, supplying PEA (CAS 544-31-0) as PEAptimize™ at 99% minimum by HPLC in standard, micronized and ultra-micronized particle-size grades, produced by organic synthesis from palmitic acid and ethanolamine, for B2B nutraceutical formulation.
For PEA the specification conversation is only half about assay. Because the material is a waxy, poorly water-soluble fatty acid amide, particle size distribution, bulk and tapped density, flowability and capsule-fill performance decide whether a formula runs on line. Every lot ships with a Certificate of Analysis stating identity, HPLC assay and the assay basis.
| Ingredient name | PEA (Palmitoylethanolamide) — PEAptimize™ |
|---|---|
| Synonyms | Palmitoylethanolamide; PEA; palmidrol; N-(2-hydroxyethyl)hexadecanamide; N-palmitoylethanolamine |
| CAS number | 544-31-0 |
| Molecular formula | C18H37NO2 |
| Molecular weight | 299.49 g/mol |
| Assay / purity | 99% minimum by HPLC, stated on the Certificate of Analysis for each lot. The particle-size grade is specified separately per order and does not change the assay specification. |
| Particle-size grades | Supplied as standard (non-micronized), micronized and ultra-micronized grades. Particle size distribution (D10/D50/D90) is measured per lot and reported on the Certificate of Analysis, with the method stated. Grades are not interchangeable: the same assay at a different particle size behaves differently in blending, capsule filling and dissolution testing. |
| Source / production route | Organic synthesis — amidation of palmitic acid with ethanolamine, followed by purification and crystallisation. PEA is an endogenous fatty acid amide also present in foods; commercial material is synthesised, not extracted. The origin of the palmitic acid feedstock (vegetable-derived, e.g. palm or other vegetable oil) is stated on the specification sheet, together with sustainability documentation where required. |
| Appearance | White to off-white crystalline or waxy powder |
| Solubility | Practically insoluble in water; soluble in ethanol, DMSO and warm lipid systems. Wetting behaviour, dispersion and dissolution medium should be confirmed for the intended dosage form. |
| Powder properties | Bulk and tapped density, angle of repose, loss on drying and sieve analysis available per lot on request — these are the parameters that govern capsule weight consistency and tablet compaction for a low-density amide. |
| Typical applications | Capsules, tablets, sachets, stick packs, chewables and softgel or lipid-matrix formats for B2B nutraceutical manufacturing |
| Documentation | Certificate of Analysis, specification sheet, identity confirmation, heavy metals, microbiological testing, residual solvents, allergen statement, GMO statement, particle size data, bulk density data, feedstock origin statement and stability data |
| Stability / storage | Store in tightly closed containers in a cool, dry place away from direct heat and light. Melting behaviour should be considered when the material is exposed to heat during granulation, tableting or lipid-phase processing. |
| Regulatory note | Permitted use, notification status and labelling requirements for palmitoylethanolamide differ by jurisdiction. Buyers are responsible for confirming the regulatory position in each market of sale before launch. |
| Quality system | ISO 22000:2018, FSSC 22000, HACCP and GMP (certificates provided on request) |
| Supplier | Nutrition BioTech, 1601 W. Mission Blvd, Suite 103 (DL#29), Pomona, CA 91766, United States |
PEA (Palmitoylethanolamide) (PEAptimize™)
PEAptimize™ PEA for neurocomfort, recovery and healthy inflammatory-response formulas.
Why brands ask for it
PEAptimize™ Palmitoylethanolamide is positioned for neurocomfort, recovery and healthy inflammatory-response formulas. For B2B formulation, the key challenge is not only assay but particle size, bulk density, flowability and capsule-filling performance.
Finished-product fit
Comfort-free active lifestyle, recovery, neurocomfort, comfort-response support, sports recovery. The strongest conversations start with format, serving size, documentation, and how the material behaves in the intended formula.
What makes the sample useful
- Micronized/ultra-micronized options
- Bulk density and capsule-fill performance matter
- Strong European/clinical story in consumer market
Before the sample ships
- Request contaminant, residual solvent, and microbiology files as needed.
- Confirm particle size.
- Confirm bulk density.
- Match the material to the target capsule, tablet, sachet, gummy, or powder format.
- Confirm it have carrier.
File Package
Ask for the material files that match your market, dosage form, and internal review process.
Available documents may include: COA / Specification / Allergen Statement / GMO Statement / Vegan Statement / Heavy Metals / Microbial Limits / Manufacturing Flow Chart / Residual Solvent / Country of Origin / Composition Statement.
Regulatory & Facility Support
Product-specific regulatory information may include Self-GRAS, NDI/NDIN, GRAS, ODI, or regulatory review notes, depending on the ingredient and target market.
Facility and quality system support may include Kosher, Halal, HACCP, ISO 22000, PCQI, c-GMP, NSF and other applicable certificates upon request.
